Unnamed Cancer Therapeutics

About ProPhase Labs

ProPhase Labs is a publicly-traded, diversified healthcare company executing a synergistic strategy across three core areas: genomics, biopharma, and consumer health. The company has generated significant revenue through its CLIA-certified lab operations and consumer products, while investing in high-potential assets like the BE-Smart esophageal cancer detection test and Equivir antiviral compounds. Led by Chairman & CEO Ted Karkus, who has a track record of building and selling companies for substantial returns, ProPhase aims to become a multibillion-dollar company through focused execution and smart diversification of its cutting-edge assets.

Therapeutic Areas